THE INVITRO ANTIBACTERIAL ACTIVITY OF A COMBINATION OF CEFPIROME OR CEFOPERAZONE WITH VANCOMYCIN AGAINST ENTEROCOCCI AND STAPHYLOCOCCUS-AUREUS

被引：25

作者：

SEIBERT, G

ISERT, D

KLESEL, N

LIMBERT, M

MARKUS, A

SCHRINNER, E

机构：

[1] Hoechst AG, SBU Anti-infectives Research, Frankfurt, 6230

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 1992年 / 29卷

关键词：

D O I：

10.1093/jac/29.suppl_A.25

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Cefpirome, cefoperazone and ceftazidime were tested for their in-vitro activity against Enterococcus faecalis and methicillin-resistant Staphylococcus aureus (MRSA) isolates. Cefpirome was the most active cephalosporin followed by cefoper- azone. Ceftazidime had only very limited activity against these strains. In experiments with cefpirome/vancomycin and cefoperazone/vancomycin combinations, synergy was detected against most MRSA strains and some enterococci. Antagonism did not occur. © 1992 Oxford University Press.

引用

页码：25 / 30

页数：6

共 7 条

[1] INVITRO EVALUATION OF CEFPIROME (HR 810), TEICOPLANIN AND 4 OTHER ANTIMICROBIALS AGAINST ENTEROCOCCI [J].